Akiko Sueoka

Partner

Akiko Sueoka

Print profile

Languages
JapaneseEnglishItalian

Contact Information

TEL
+81-3-5223-7772
FAX
+81-3-5223-7672

Practice Areas

Work Highlights

Akiko Sueoka:Awards

Awards
The Best Lawyers in Japan™ and Best Lawyers: Ones to Watch in Japan™ (2024 edition)
Awards
Lawyers from Mori Hamada & Matsumoto were included in the 13th edition of The Best Lawyers in Japan™ and the inaugural Best Lawyers: Ones to Watch in Japan™
Awards
Lawyers from Mori Hamada & Matsumoto were included in the 12th edition of The Best Lawyers™ in Japan

View All

Akiko Sueoka:News

Works
MHM obtains a final judgment in favor of the taxpayer in tax litigation regarding the reorganization of its subsidiary
Public Service
Akiko Sueoka becomes a member of Study Group on Distribution Systems for Pharmaceuticals, Ministry of Health, Labour and Welfare of Japan
Public Service
Akiko Sueoka becomes a member of Subcommittee on Medical Devices and In-Vitro Diagnostic Reagents, Pharmaceutical Affairs and Food Sanitation Council, Ministry of Health, Labour and Welfare of Japan

View All

Akiko Sueoka:Seminars

Jul. 7, 2021External Seminars
"The Fundamentals of International Legal Business Practice: Global Trends in Changing Times"
Jun. 4, 2019External Seminars
"18th Annual International Mergers & Acquisitions Conference 『Global M&A hot topics』"
Dec. 15, 2016External Seminars
"150 Years of Friendship and Commerce: Business Law in Italy and Japan between Past and Present(Rome)"

View All

Akiko Sueoka:Publications

Book
”Comprehensive Analysis of M&A Laws of Japan, 2nd edition”
Book
"Q&A: Digital Health and Law [2nd ed.]"
Article
"Getting the Deal Through - Healthcare M&A 2021 - Japan Chapter"

View All

Akiko Sueoka:Other

Background

  • Keio University (LL.B., 1994)
  • The Ministry of Health and Welfare (Currently, Ministry of Health, Labour and Welfare) (1994-1998)
  • The Institute of Fiscal and Monetary Policy, the Ministry of Finance (Currently, Policy Research Institute, Ministry of Finance) (1995)
  • Harvard Law School (LL.M., 2003)
  • with Simpson Thacher & Bartlett, New York (2003-2004)
  • with Pavia e Ansaldo, Rome (2004-2005)
  • seconded to the Ministry of Economy, Trade and Industry (Associate Director) (in charge of the Corporate Law, the Limited Partnership Act for Investment, the Limited Liability Partnership Act and M&A) (2005-2006)

Major Activities

  • Member of International Committee, Tokyo Bar Association (2009-)
  • Member of the Investment Project Promotion Committee, Tohoku University (2016-)
  • Member of the Committee for the Promotion of Commercialization through Industry-University Joint Research, Tohoku University (2017-)
  • Outside Director of Hakudo Co., Ltd. (Audit and Supervisory Committee Member) (2019-)
  • Outside Auditor of Japan Investment Corporation (2020-)
  • Member of the Expert Committee for System Design under the Electricity and Gas Market Surveillance Commission, Ministry of Economy, Trade and Industry (2021-)
  • Member of Tokyo Metropolitan Pharmaceutical Affairs Council (2021-)
  • Outside Auditor of Change Inc. (Currently, CHANGE Holdings, Inc.) (2022-2023)
  • Member of Pharmaceutical Affairs Council, Pharmaceutical Affairs and Food Sanitation Council, Ministry of Health, Labour and Welfare of Japan (2023-)
  • Member of the Second Committee on New Drugs, Pharmaceutical Affairs Council, Pharmaceutical Affairs and Food Sanitation Council, Ministry of Health, Labour and Welfare of Japan (2023-)
  • Member of Subcommittee on Medical Devices and In-Vitro Diagnostic Reagents, Pharmaceutical Affairs and Food Sanitation Council, Ministry of Health, Labour and Welfare of Japan (2023-)
  • Investigator of SaMD Investigation Commission, Subcommittee on Medical Devices and  In-Vitro Diagnostic Reagents, Pharmaceutical Affairs and Food Sanitation Council, Ministry of Health, Labour and Welfare of Japan (2023-)
  • Member of Study Group on Distribution Systems for Pharmaceuticals, Ministry of Health, Labour and Welfare of Japan (2023-)

Practice Group

  • M&A
  • Healthcare/Life Sciences (Pharmaceuticals)
  • Energy & Infrastructure
  • Ventures/Equity Fund

Bar Admissions

admitted in Japan, 2000; New York, 2004
Tokyo Bar Association